Ocular Comorbidity in Atopic Dermatitis
NCT04973384 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2024-11-15
Summary
A clinical characterization of a large cohort of patients with different severities of AD and ocular symptoms/atopic keratoconjunktivitis (AKC). The data will contribute to assess the frequency of complications in order to give a rationale for focused prevention and treatment strategy.
Conditions
- Atopic Keratoconjunctivitis
Sponsors & Collaborators
-
Oslo University Hospital
collaborator OTHER -
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Steffen Heegaard, MD, DMSci · Department of Ophthalmology, Rigshospitalet-Glostrup
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-05
- Primary Completion
- 2024-02-14
- Completion
- 2026-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis
NCT04287608 ·Status: COMPLETED
-
Characterisation of Skin Microstructure Under Normal and Atrophied States
NCT06954272 ·Status: RECRUITING
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries
NCT05214326 ·Status: COMPLETED
-
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
NCT04836858 ·Status: COMPLETED ·Phase: PHASE2
-
Distribution of Tacrolimus in Skin, Atopic Dermatitis
NCT00534508 ·Status: COMPLETED ·Phase: PHASE2
-
Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up
NCT00795496 ·Status: COMPLETED
-
Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)
NCT03823794 ·Status: COMPLETED
-
Ophthalmological Adverse Events of Tralokinumab in AD
NCT05682976 ·Status: COMPLETED
-
Prospective Longitudinal Observational Research in Atopic Dermatitis
NCT04240522 ·Status: RECRUITING
-
Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
NCT01149759 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis
NCT00310492 ·Status: COMPLETED ·Phase: PHASE3
-
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
NCT05098821 ·Status: RECRUITING
-
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
NCT06174493 ·Status: NOT_YET_RECRUITING
-
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT05507580 ·Status: COMPLETED ·Phase: PHASE4
-
MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement
NCT06455891 ·Status: COMPLETED
-
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
NCT05916365 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis
NCT04256174 ·Status: COMPLETED ·Phase: PHASE1
-
Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
NCT06983561 ·Status: COMPLETED
-
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
NCT00480610 ·Status: COMPLETED ·Phase: PHASE3
-
Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB Treatment
NCT03402412 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD
NCT05639738 ·Status: TERMINATED ·Phase: NA
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2